{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:36:12Z","timestamp":1786988172010,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Surgical Oncology (EJSO)"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.ejso.2010.01.001","type":"journal-article","created":{"date-parts":[[2010,1,26]],"date-time":"2010-01-26T05:07:32Z","timestamp":1264482452000},"page":"414-421","source":"Crossref","is-referenced-by-count":84,"title":["Dual PET\/CT with 18F-DOPA and 18F-FDG in metastatic medullary thyroid carcinoma and rapidly increasing calcitonin levels: Comparison with conventional imaging"],"prefix":"10.1016","volume":"36","author":[{"given":"M.C.","family":"Marzola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.R.","family":"Pelizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ferdeghini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Toniato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Massaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Ambrosini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Fanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.D.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Al-Nahhas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Rubello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2010.01.001_bib1","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5<1139::AID-CNCR26>3.0.CO;2-Z","article-title":"Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems","volume":"88","author":"Kebebew","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2010.01.001_bib2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1677\/erc.0.0080135","article-title":"Treatment of medullary thyroid carcinoma: an update","volume":"8","author":"Orlandi","year":"2001","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ejso.2010.01.001_bib3","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/00000658-199906000-00016","article-title":"Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection","volume":"229","author":"Moley","year":"1999","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2010.01.001_bib4","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.surg.2009.06.007","article-title":"Long-term outcome of \u201cprophylactic therapy\u201d for familial medullary thyroid cancer","volume":"146","author":"Schellhaas","year":"2009","journal-title":"Surgery"},{"key":"10.1016\/j.ejso.2010.01.001_bib5","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/hed.20609","article-title":"Locoregional control in patients with palpable medullary thyroid cancer: results of standardized compartment-oriented surgery","volume":"29","author":"de Groot","year":"2007","journal-title":"Head Neck"},{"key":"10.1016\/j.ejso.2010.01.001_bib6","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/MNM.0b013e32830f4af2","article-title":"Functional nuclear imaging of medullary thyroid cancer","volume":"29","author":"Bozkurt","year":"2008","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.ejso.2010.01.001_bib7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF01367593","article-title":"Comparison of 99mTc(V)-DMSA, 201Tl and 99mTc-MIBI imaging in the follow-up of patients with medullary carcinoma of the thyroid","volume":"23","author":"Ugur","year":"1996","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.ejso.2010.01.001_bib8","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1007\/s002590050325","article-title":"Use of somatostatin analogue scintigraphy in the localization of recurrent medullary thyroid carcinoma","volume":"25","author":"Berna","year":"1998","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.ejso.2010.01.001_bib9","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00003072-199904000-00008","article-title":"Somatostatin receptor scintigraphy for early detection of regional and distant metastases of medullary carcinoma of the thyroid","volume":"24","author":"Krausz","year":"1999","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.ejso.2010.01.001_bib10","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00006231-199904000-00010","article-title":"Determination of medullary thyroid carcinoma metastases by 201Tl, 99Tcm(V)DMSA, 99Tcm-MIBI and 99Tcm-tetrofosmin","volume":"20","author":"Adalet","year":"1999","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.ejso.2010.01.001_bib11","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s00330-008-1280-7","article-title":"The value of 18F-DOPA PET-CT in patients with medullary thyroid carcinoma: comparison with 18F-FDG PET-CT","volume":"19","author":"Beheshti","year":"2009","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ejso.2010.01.001_bib12","first-page":"67","article-title":"Role of PET in medullary thyroid carcinoma","volume":"33","author":"Rufini","year":"2008","journal-title":"Minerva Endocrinol"},{"key":"10.1016\/j.ejso.2010.01.001_bib13","doi-asserted-by":"crossref","first-page":"524","DOI":"10.2967\/jnumed.107.047720","article-title":"18F-dihydroxyphenylalanine PET in patients with biochemical evidence of medullary thyroid cancer: relation to tumor differentiation","volume":"49","author":"Koopmans","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejso.2010.01.001_bib14","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1007\/s00259-007-0425-2","article-title":"Diagnostic impact of PET with 18F-FDG, 18F-DOPA and 3-O-methyl-6-[18F]fluoro-DOPA in recurrent or metastatic medullary thyroid carcinoma","volume":"34","author":"Beuthien-Baumann","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ejso.2010.01.001_bib15","first-page":"277","article-title":"Clinical applications of 68Ga-DOTANOC in neuroendocrine tumours","volume":"33","author":"Lopci","year":"2008","journal-title":"Minerva Endocrinol"},{"key":"10.1016\/j.ejso.2010.01.001_bib16","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.biopha.2008.01.010","article-title":"Evaluation of unusual neuroendocrine tumours by means of 68Ga-DOTA-NOC PET","volume":"62","author":"Fanti","year":"2008","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ejso.2010.01.001_bib17","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ejso.2006.10.021","article-title":"Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients","volume":"33","author":"Pelizzo","year":"2007","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2010.01.001_bib18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2265.2008.03229.x","article-title":"Long-term prognosis of medullary thyroid carcinoma","volume":"69","author":"Rendl","year":"2008","journal-title":"Clinical Endocrinol."},{"key":"10.1016\/j.ejso.2010.01.001_bib19","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1002\/cncr.22244","article-title":"Prognosis of medullary thyroid carcinoma","volume":"107","author":"Roman","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2010.01.001_bib20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2217\/14796694.5.1.75","article-title":"Update on nuclear medicine imaging of neuroendocrine tumors","volume":"5","author":"Goldsmith","year":"2009","journal-title":"Future Oncol."},{"key":"10.1016\/j.ejso.2010.01.001_bib21","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1053\/j.semnuclmed.2006.03.007","article-title":"Imaging of neuroendocrine tumors","volume":"36","author":"Rufini","year":"2006","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.ejso.2010.01.001_bib22","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1245\/ASO.2004.10.015","article-title":"Impact of 18F-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) in patients with biochemical evidence of recurrent or residual medullary thyroid cancer","volume":"11","author":"de Groot","year":"2004","journal-title":"Ann Surg Oncol."},{"key":"10.1016\/j.ejso.2010.01.001_bib23","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1177\/107327480501200408","article-title":"Review of fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in the follow-up of medullary and anaplastic thyroid carcinomas","volume":"12","author":"Khan","year":"2005","journal-title":"Cancer Control."},{"key":"10.1016\/j.ejso.2010.01.001_bib24","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11307-006-0072-1","article-title":"Detection of occult medullary thyroid cancer recurrence with 2-deoxy-2-[F-18]fluoro-d-glucose-PET and PET\/CT","volume":"9","author":"Iagaru","year":"2007","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.ejso.2010.01.001_bib25","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ejso.2007.08.005","article-title":"The role of 18F-FDG PET\/CT in detecting metastatic deposits of recurrent medullary thyroid carcinoma: a prospective study","volume":"34","author":"Rubello","year":"2008","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2010.01.001_bib26","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/00006231-200405000-00003","article-title":"18F-FDG PET, somatostatin receptor scintigraphy, and CT in metastatic medullary thyroid carcinoma: a clinical study and an analysis of the literature","volume":"25","author":"Gotthardt","year":"2004","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.ejso.2010.01.001_bib27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.rcl.2004.08.002","article-title":"Role of [18F]-DOPA PET imaging in assessment movement disorders","volume":"43","author":"Fischman","year":"2005","journal-title":"Radiol Clin North Am."},{"key":"10.1016\/j.ejso.2010.01.001_bib28","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1210\/jc.2006-1479","article-title":"Fluorine-18-l-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patients","volume":"92","author":"Kauhanen","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab."},{"key":"10.1016\/j.ejso.2010.01.001_bib29","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/MNM.0b013e3282ffd70d","article-title":"68Ga-DOTA-peptides versus 18F-DOPA PET for the assessment of NET patients","volume":"29","author":"Ambrosini","year":"2008","journal-title":"Nucl Med Commun."},{"key":"10.1016\/j.ejso.2010.01.001_bib30","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s002590000404","article-title":"18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels","volume":"28","author":"Hoegerle","year":"2001","journal-title":"Eur J Nucl Med"}],"container-title":["European Journal of Surgical Oncology (EJSO)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798310000028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798310000028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,25]],"date-time":"2019-05-25T06:20:39Z","timestamp":1558765239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798310000028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0748798310000028"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2010.01.001","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}